TNF and rheumatoid arthritis: PGRN demonstrates therapeutic potential by effectively counteracting TNF-α-driven effects through inflammation-bone coupling mediation and OB differentiation promotion, suggesting its viability as a novel therapeutic target for RA management (Figure 3).